{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T20:19:38Z","timestamp":1787429978570,"version":"build-2736575974"},"reference-count":62,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.antiviral.2011.08.016","type":"journal-article","created":{"date-parts":[[2011,8,27]],"date-time":"2011-08-27T13:00:36Z","timestamp":1314450036000},"page":"292-304","source":"Crossref","is-referenced-by-count":31,"title":["An attenuated EIAV vaccine strain induces significantly different immune responses from its pathogenic parental strain although with similar in vivo replication pattern"],"prefix":"10.1016","volume":"92","author":[{"given":"Yue-Zhi","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong-Xian","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen-Ying","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi-Lin","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-Zhi","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-Feng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Gang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Ping","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Ling","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Ming","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Hua","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2011.08.016_b0005","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1002\/eji.200939551","article-title":"25 years of HIV research!... and what about a vaccine?","volume":"39","author":"Appay","year":"2009","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.antiviral.2011.08.016_b0010","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1517\/14712590802571928","article-title":"Elite control of HIV infection: implications for vaccine design","volume":"9","author":"Baker","year":"2009","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.antiviral.2011.08.016_b0015","doi-asserted-by":"crossref","first-page":"578","DOI":"10.2174\/157016207782418461","article-title":"Transmission of HIV-1 in the face of neutralizing antibodies","volume":"5","author":"Blish","year":"2007","journal-title":"Curr. HIV Res."},{"key":"10.1016\/j.antiviral.2011.08.016_b0020","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.vetimm.2004.09.024","article-title":"Equine herpesvirus-1 infection induces IFN-gamma production by equine T lymphocyte subsets","volume":"103","author":"Breathnach","year":"2005","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.antiviral.2011.08.016_b0025","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.virol.2004.06.035","article-title":"CTL from EIAV carrier horses with diverse MHC class I alleles recognize epitope clusters in Gag matrix and capsid proteins","volume":"327","author":"Chung","year":"2004","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2011.08.016_b0030","first-page":"11","article-title":"Diagnosis of equine infectious anemia by immunodiffusion test","volume":"33","author":"Coggins","year":"1972","journal-title":"Am. J. Vet. Res."},{"key":"10.1016\/j.antiviral.2011.08.016_b0040","doi-asserted-by":"crossref","first-page":"5069","DOI":"10.1128\/JVI.71.7.5069-5079.1997","article-title":"Evolution of envelope-specific antibody responses in monkeys experimentally infected or immunized with simian immunodeficiency virus and its association with the development of protective immunity","volume":"71","author":"Cole","year":"1997","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2011.08.016_b0035","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1034\/j.1600-0684.2000.290315.x","article-title":"Maturation of envelope-specific antibody responses to linear determinants in monkeys inoculated with attenuated SIV","volume":"29","author":"Cole","year":"2000","journal-title":"J. Med. Primatol."},{"key":"10.1016\/j.antiviral.2011.08.016_b0045","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.virol.2009.11.005","article-title":"EIAV S2 enhances pro-inflammatory cytokine and chemokine response in infected macrophages","volume":"397","author":"Covaleda","year":"2010","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2011.08.016_b0060","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2174\/157016210790416398","article-title":"EIAV envelope diversity: shaping viral persistence and encumbering vaccine efficacy","volume":"8","author":"Craigo","year":"2010","journal-title":"Curr. HIV Res."},{"key":"10.1016\/j.antiviral.2011.08.016_b0065","doi-asserted-by":"crossref","first-page":"139","DOI":"10.2217\/fvl.10.85","article-title":"Equine infectious anemia virus infection and immunity: lessons for aids vaccine development","volume":"6","author":"Craigo","year":"2011","journal-title":"Future Virol."},{"key":"10.1016\/j.antiviral.2011.08.016_b0050","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1099\/0022-1317-83-6-1353","article-title":"Transient immune suppression of inapparent carriers infected with a principal neutralizing domain-deficient equine infectious anaemia virus induces neutralizing antibodies and lowers steady-state virus replication","volume":"83","author":"Craigo","year":"2002","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2011.08.016_b0055","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1128\/JVI.79.5.2666-2677.2005","article-title":"Discerning an effective balance between equine infectious anemia virus attenuation and vaccine efficacy","volume":"79","author":"Craigo","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2011.08.016_b0070","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1006\/viro.1996.8419","article-title":"Macaques infected with live attenuated SIVmac are protected against superinfection via the rectal mucosa","volume":"229","author":"Cranage","year":"1997","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2011.08.016_b0075","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/1742-4690-5-112","article-title":"Mechanisms of HIV non-progression; robust and sustained CD4+ T-cell proliferative responses to p24 antigen correlate with control of viraemia and lack of disease progression after long-term transfusion-acquired HIV-1 infection","volume":"5","author":"Dyer","year":"2008","journal-title":"Retrovirology"},{"key":"10.1016\/j.antiviral.2011.08.016_b0080","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1093\/infdis\/166.6.1217","article-title":"Association of antibody to human immunodeficiency virus type 1 core protein (p24), CD4+ lymphocyte number, and AIDS-free time","volume":"166","author":"Farzadegan","year":"1992","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2011.08.016_b0085","doi-asserted-by":"crossref","first-page":"147","DOI":"10.4149\/av_2009_03_147","article-title":"A CFSE-based assay of proliferative response of lymphocytes to stimulation with dengue viruses","volume":"53","author":"Gil","year":"2009","journal-title":"Acta Virol."},{"key":"10.1016\/j.antiviral.2011.08.016_b0090","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1093\/infdis\/jiq152","article-title":"Statistical interpretation of the RV144 HIV vaccine efficacy trial in Thailand: a case study for statistical issues in efficacy trials","volume":"203","author":"Gilbert","year":"2011","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2011.08.016_b0095","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1128\/JVI.78.2.551-560.2004","article-title":"Important role for the CA-NC spacer region in the assembly of bovine immunodeficiency virus Gag protein","volume":"78","author":"Guo","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2011.08.016_b0100","doi-asserted-by":"crossref","first-page":"3840","DOI":"10.1128\/JVI.71.5.3840-3852.1997","article-title":"Maturation of the cellular and humoral immune responses to persistent infection in horses by equine infectious anemia virus is a complex and lengthy process","volume":"71","author":"Hammond","year":"1997","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2011.08.016_b0110","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1006\/viro.1999.9939","article-title":"Evaluation of antibody parameters as potential correlates of protection or enhancement by experimental vaccines to equine infectious anemia virus","volume":"262","author":"Hammond","year":"1999","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2011.08.016_b0105","doi-asserted-by":"crossref","first-page":"5968","DOI":"10.1128\/JVI.74.13.5968-5981.2000","article-title":"Immune responses and viral replication in long-term inapparent carrier ponies inoculated with equine infectious anemia virus","volume":"74","author":"Hammond","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2011.08.016_b0115","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1586\/14760584.7.3.303","article-title":"STEP trial and HIV-1 vaccines inducing T-cell responses","volume":"7","author":"Hanke","year":"2008","journal-title":"Expert Rev. Vacc."},{"key":"10.1016\/j.antiviral.2011.08.016_b0120","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1377\/hlthaff.28.6.1642","article-title":"Why we don\u2019t have an HIV vaccine, and how we can develop one","volume":"28","author":"Harris","year":"2009","journal-title":"Health Aff. (Millwood)"},{"key":"10.1016\/j.antiviral.2011.08.016_b0125","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1128\/JVI.74.7.3112-3121.2000","article-title":"Tissue sites of persistent infection and active replication of equine infectious anemia virus during acute disease and asymptomatic infection in experimentally infected equids","volume":"74","author":"Harrold","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2011.08.016_b0130","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.virol.2005.08.042","article-title":"Analysis of HIV-1 subtype B third variable region peptide motifs for induction of neutralizing antibodies against HIV-1 primary isolates","volume":"345","author":"Haynes","year":"2006","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2011.08.016_b0135","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/ni1296","article-title":"HIV vaccine design: insights from live attenuated SIV vaccines","volume":"7","author":"Koff","year":"2006","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.antiviral.2011.08.016_b0140","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.chom.2009.09.008","article-title":"Mining the B cell repertoire for broadly neutralizing monoclonal antibodies to HIV-1","volume":"6","author":"Kwong","year":"2009","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.antiviral.2011.08.016_b0145","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1128\/JCM.34.6.1481-1487.1996","article-title":"Detection of equine infectious anemia viral RNA in plasma samples from recently infected and long-term inapparent carrier animals by PCR","volume":"34","author":"Langemeier","year":"1996","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.antiviral.2011.08.016_b0150","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1051\/vetres:2004020","article-title":"Equine Infectious Anemia Virus (EIAV): what has HIV\u2019s country cousin got to tell us?","volume":"35","author":"Leroux","year":"2004","journal-title":"Vet. Res."},{"key":"10.1016\/j.antiviral.2011.08.016_b0155","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1038\/nri1959","article-title":"Progress and obstacles in the development of an AIDS vaccine","volume":"6","author":"Letvin","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.antiviral.2011.08.016_b0160","doi-asserted-by":"crossref","first-page":"7244","DOI":"10.1128\/JVI.77.13.7244-7253.2003","article-title":"A live attenuated equine infectious anemia virus proviral vaccine with a modified S2 gene provides protection from detectable infection by intravenous virulent virus challenge of experimentally inoculated horses","volume":"77","author":"Li","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2011.08.016_b0165","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nature07469","article-title":"Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeys","volume":"457","author":"Liu","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2011.08.016_b0170","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s00705-009-0378-9","article-title":"In vivo evolution of the gp90 gene and consistently low plasma viral load during transient immune suppression demonstrate the safety of an attenuated equine infectious anemia virus (EIAV) vaccine","volume":"154","author":"Ma","year":"2009","journal-title":"Arch. Virol."},{"key":"10.1016\/j.antiviral.2011.08.016_b0175","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1128\/JVI.00015-08","article-title":"Vaccine protection by live, attenuated simian immunodeficiency virus in the absence of high-titer antibody responses and high-frequency cellular immune responses measurable in the periphery","volume":"82","author":"Mansfield","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2011.08.016_b0180","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1089\/088282402320914476","article-title":"Cytotoxic T lymphocytes and neutralizing antibody in the control of equine infectious anemia virus","volume":"15","author":"McGuire","year":"2002","journal-title":"Viral Immunol."},{"key":"10.1016\/j.antiviral.2011.08.016_b0185","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1742-4690-7-54","article-title":"Innate immune recognition and activation during HIV infection","volume":"7","author":"Mogensen","year":"2010","journal-title":"Retrovirology"},{"issue":"Suppl. 3","key":"10.1016\/j.antiviral.2011.08.016_b0320","first-page":"S255","article-title":"Maturation of immune responses to lentivirus infection: implications for AIDS vaccine development","volume":"14","author":"Montelaro","year":"1998","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.antiviral.2011.08.016_b0200","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0042-6822(91)90821-R","article-title":"Transient suppression of equine immune responses by equine infectious anemia virus (EIAV)","volume":"184","author":"Newman","year":"1991","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2011.08.016_b0205","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.1128\/JVI.62.8.3073-3076.1988","article-title":"Immune responses are required to terminate viremia in equine infectious anemia lentivirus infection","volume":"62","author":"Perryman","year":"1988","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2011.08.016_b0210","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.prevetmed.2006.10.009","article-title":"Serodiagnosis of equine infectious anemia by agar gel immunodiffusion and ELISA using a recombinant p26 viral protein expressed in Escherichia coli as antigen","volume":"78","author":"Piza","year":"2007","journal-title":"Prev. Vet. Med."},{"key":"10.1016\/j.antiviral.2011.08.016_b0215","first-page":"1","article-title":"Neutralization of HIV by antibodies","volume":"525","author":"Prado","year":"2009","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.antiviral.2011.08.016_b0220","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1084\/jem.20081524","article-title":"Macaques vaccinated with live-attenuated SIV control replication of heterologous virus","volume":"205","author":"Reynolds","year":"2008","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.antiviral.2011.08.016_b0225","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/S0140-6736(08)61593-7","article-title":"Failure of the Merck HIV vaccine: an uncertain step forward","volume":"372","author":"Robb","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2011.08.016_b0230","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0022-1759(90)90399-G","article-title":"A novel enzyme-linked immunosorbent assay (ELISA) for the detection of antibodies to HIV-1 envelope glycoproteins based on immobilization of viral glycoproteins in microtiter wells coated with concanavalin A","volume":"132","author":"Robinson","year":"1990","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.antiviral.2011.08.016_b0235","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0165-2478(98)00165-5","article-title":"Characterization of HIV-1-specific T-helper cells in acute and chronic infection","volume":"66","author":"Rosenberg","year":"1999","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.antiviral.2011.08.016_b0240","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1172\/JCI118845","article-title":"Pathogenic and protective correlates of T cell proliferation in AIDS. HNRC Group. HIV Neurobehavioral Research Center","volume":"98","author":"Schrier","year":"1996","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.antiviral.2011.08.016_b0245","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/ni969","article-title":"Similarities and differences in CD4+ and CD8+ effector and memory T cell generation","volume":"4","author":"Seder","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.antiviral.2011.08.016_b0250","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nri2274","article-title":"T-cell quality in memory and protection: implications for vaccine design","volume":"8","author":"Seder","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.antiviral.2011.08.016_b0255","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.2460\/ajvr.1984.45.08.1542","article-title":"Enzyme-linked immunosorbent assay for detection of equine infectious anemia antibody to purified P26 viral protein","volume":"45","author":"Shen","year":"1984","journal-title":"Am. J. Vet. Res."},{"key":"10.1016\/j.antiviral.2011.08.016_b0260","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.vaccine.2005.08.084","article-title":"Amino acid mutations of the infectious clone from Chinese EIAV attenuated vaccine resulted in reversion of virulence","volume":"24","author":"Shen","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2011.08.016_b0270","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1099\/vir.0.82391-0","article-title":"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus","volume":"88","author":"Tagmyer","year":"2007","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2011.08.016_b0265","doi-asserted-by":"crossref","first-page":"4052","DOI":"10.1128\/JVI.02028-07","article-title":"Envelope determinants of equine infectious anemia virus vaccine protection and the effects of sequence variation on immune recognition","volume":"82","author":"Tagmyer","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2011.08.016_b0275","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.tim.2008.08.010","article-title":"Relevance of studying T cell responses in SIV-infected rhesus macaques","volume":"16","author":"Valentine","year":"2008","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.antiviral.2011.08.016_b0280","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00705-010-0877-8","article-title":"Genomic comparison between attenuated Chinese equine infectious anemia virus vaccine strains and their parental virulent strains","volume":"156","author":"Wang","year":"2011","journal-title":"Arch. Virol."},{"key":"10.1016\/j.antiviral.2011.08.016_b0285","first-page":"35","article-title":"HIV vaccine development","volume":"18","author":"Watkins","year":"2010","journal-title":"Top. HIV Med."},{"key":"10.1016\/j.antiviral.2011.08.016_b0290","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/00001432-200402000-00004","article-title":"Live attenuated HIV vaccines: pitfalls and prospects","volume":"17","author":"Whitney","year":"2004","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2011.08.016_b0325","first-page":"25","article-title":"Advanced application of CFSE for cellular tracking","author":"Witkowski","year":"2008","journal-title":"Curr. Protoc. Cytom."},{"key":"10.1016\/j.antiviral.2011.08.016_b0300","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.virol.2008.05.017","article-title":"Immunity and protection by live attenuated HIV\/SIV vaccines","volume":"378","author":"Wodarz","year":"2008","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2011.08.016_b0305","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.virol.2008.09.038","article-title":"Longitudinal study to assess the safety and efficacy of a live-attenuated SHIV vaccine in long term immunized rhesus macaques","volume":"383","author":"Yankee","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2011.08.016_b0310","doi-asserted-by":"crossref","first-page":"9612","DOI":"10.1128\/JVI.72.12.9612-9620.1998","article-title":"Gag protein epitopes recognized by ELA-A-restricted cytotoxic T lymphocytes from horses with long-term equine infectious anemia virus infection","volume":"72","author":"Zhang","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2011.08.016_b0315","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1099\/vir.0.82416-0","article-title":"Correlation between the induction of Th1 cytokines by an attenuated equine infectious anemia virus vaccine and protection against disease progression","volume":"88","author":"Zhang","year":"2007","journal-title":"J. Gen. Virol."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354211004177?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354211004177?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,9]],"date-time":"2025-03-09T10:32:05Z","timestamp":1741516325000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354211004177"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":62,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S0166354211004177"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2011.08.016","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}